Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy

International Journal of Experimental Pathology

Volumn 90, Issue 3, 2009, Pages 338-346

  Gürtl, Barbara ^a   Kratky, Dagmar ^a   Guelly, Christian ^a   Zhang, Lefeng ^a   Gorkiewicz, Gregor ^a   Das, Suman Kumar ^a   Tamilarasan, Kuppusamy Palaniappan ^a   Hoefler, Gerald ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

tubulin; Apoptosis; Fibrosis; Lipoprotein lipase; Metabolic cardiomyopathy; PPAR

Indexed keywords

ALPHA TUBULIN; ANILINE; CASPASE 3; COLLAGEN; COMPLEMENTARY DNA; LIPOPROTEIN LIPASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TUBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL; CARDIOMYOPATHY; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; DNA MICROARRAY; GENE EXPRESSION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; METABOLIC CARDIOMYOPATHY; MORPHOLOGY; MOUSE; MOUSE STRAIN; MYOCARDIAL DISEASE; NONHUMAN; NORTHERN BLOTTING; PATH ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; BLOTTING, NORTHERN; CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; FIBROSIS; GENE EXPRESSION; HEART FAILURE; LIPOPROTEIN LIPASE; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PPAR ALPHA; RNA, MESSENGER; TUBULIN;

EID: 65549152293     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2009.00647.x     Document Type: Article

References (47)

1. Bernecker O.Y., Huq F., Heist E.K., Podesser B.K., Hajjar R.J. (2003) Apoptosis in heart failure and the senescent heart. Cardiovasc. Toxicol. 3, 183 190. (Pubitemid 37296072)
2. Brandt J.M., Djouadi F., Kelly D.P. (1998) Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-acitvated receptor α. J. Biol. Chem. 273, 23786 23792. (Pubitemid 28435712)
3. Campbell F.M., Kozak R., Wagner A. et al. (2002) A role for peroxisome proliferator activated receptor α (PPARα) in the control of cardiac malonyl-CoA levels. J. Biol. Chem. 277, 4098 4103.
4. Darras B.T. Friedman N.R. (2000) Metabolic myopathies: a clinical approach. Part I. Pediatr. Neurol. 22, 87 97. (Pubitemid 30109327)
5. Diez J. (2007) Mechanisms of cardiac fibrosis in hypertension. J. Clin. Hypertens. 9, 546 550.
6. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W. (1992) Control of the peroxisomal b-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68, 879 887.
7. Dyntar D., Eppenberger-Eberhardt M., Maedler K. et al. (2001) Glucose and Palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes. Diabetes 50, 2105 2113. (Pubitemid 33643679)
8. Finck B.N., Lehmann J.J., Leone T.C. et al. (2002) The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J. Clin. Invest. 109, 121 130. (Pubitemid 34052548)
9. Foo R.S., Mani K., Kitsis R.N. (2005) Death begets failure in the heart. J. Clin. Invest. 115, 565 571. (Pubitemid 40322226)
10. Francis G.A., Annicotte J.S., Auwerx J. (2003) PPAR-alpha effects on the heart and other vascular tissues. Am. J. Physiol. Heart Circ. Physiol. 285, H1 H9. (Pubitemid 36736408)
11. Gilbert-Barness E. (2004) Review: metabolic cardiomyopathy and conduction system defects in children. Ann. Clin. Lab. Sci. 34, 15 34. (Pubitemid 38280301)
12. Glatz J.F.C. VanderVusse G.J. (1996) Cellular fatty acid-binding proteins: their function and physiological significance. Prog. Lipid Res. 35, 243 282. (Pubitemid 27092444)
13. Guellich A., Damy T., Lecarpentier Y. et al. (2007) Role of oxidative stress in cardiac dysfunction of PPAR [alpha]-/- mice. Am. J. Physiol. Heart Circ. Physiol. 293, H93 H102.
14. Guerra S., Leri A., Wang X. et al. (1999) Myocyte death in the failing human heart is gender dependent. Circ. Res. 85, 856 866. (Pubitemid 29504161)
15. Hein S. Schaper J. (1996) The cytoskeleton of cardiomyocytes is altered in the failing human heart. Heart Fail. 12, 128 136. (Pubitemid 29110219)
16. Hein S., Kostin S., Heling A., Maeno Y., Schaper J. (2000) The role of cytoskeleton in heart failure. Cardiovasc. Res. 45, 273 278. (Pubitemid 30069492)
17. Heling A., Zimmermann R., Kostin S. et al. (2000) Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ. Res. 86, 846 853. (Pubitemid 30246981)
18. Höfler G., Nöhammer C., Levak-Frank S. et al. (1997) Muscle-specific overexpression of human lipoprotein lipase in mice causes increased intracellular free fatty acids and induction of peroxisomal enzymes. Biochimie 79, 163 168. (Pubitemid 27290360)
19. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., Wahli W. (1999) Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103, 1489 1498.
20. Kitamura M., Shimizu M., Ino H. et al. (2001) Collagen remodelling and cardiac dysfunction in patients with hypertrophic cardiomyopathy: the significance of type III and VI collagens. Clin. Cardiol. 24, 325 329. (Pubitemid 32285316)
21. Kostin S., Hein S., Arnon E., Scholz D., Schaper J. (2000) The cytoskeleton and related proteins in the human failing heart. Heart Fail. Rev. 5, 271 280.
22. Lee S.T., Pineau T., Drago J. et al. (1995) Targeted disruption of the a isoform of the peroxisome proliferator-activated receptor gene in mice results in an abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15, 3012 3022.
23. Leone T.C., Weinheimer C.J., Kelly D.P. (1999) A critical role for the peroxisome proliferator-activator receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty oxidation disorders. Proc. Natl Acad. Sci. USA 96, 7473 7478. (Pubitemid 29299686)
24. Levak-Frank S., Radner H., Walsh A. et al. (1995) Muscle-specific overexpression of lipoprotein lipase causes severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J. Clin. Invest. 96, 976 986.
25. Lopaschuk G.D., Belke D.D., Gamble J., Itoi T., Schönekess B.O. (1994) Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim. Biophys. Acta 1213, 263 276. (Pubitemid 24262910)
26. Mandard S., Muller M., Kersten S. (2004) Peroxisome proliferator- activated receptor alpha target genes. Cell. Mol. Life Sci. 61, 393 416. (Pubitemid 38316578)
27. Martinasso G., Oraldi M., Trombetta A. et al. (2007) Involvement of PPARs in cell proliferation and apoptosis in human colon cancer specimens and in normal and cancer cell lines. PPAR Res. 2007, 1 9. (Pubitemid 46609369)
28. Martos R., Baugh J., Ledwidge M. et al. (2007) Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 115, 888 895. (Pubitemid 46294729)
29. Muzio G., Maggiora M., Oraldi M., Trombetta A., Canuto R.A. (2007) PPARalpha and PP2A are involved in the proapoptotic effect of conjuagted linoleic acid on human hepatoma cell line SK-HEP-1. Int. J. Cancer 121, 2395 2401. (Pubitemid 350022408)
30. Nöhammer C., Brunner F., Wölkart G. et al. (2003) Myocardial dysfunction and male mortality in peroxisome proliferator-activated receptor alpha knock-out mice overexpressing lipoprotein lipase in muscle. Lab. Invest. 83, 259 269. (Pubitemid 36255370)
31. Olivetti G., Abbi R., Quaini F. et al. (1997) Apoptosis in the failing human heart. N. Engl. J. Med. 336, 1131 1141. (Pubitemid 27374695)
32. Pruimboom-Brees I., Haghpassand M., Royer L. et al. (2006) A critical role for peroxismal proliferator-activated receptor-α nuclear receptors in the development of cardiomyocyte degeneration and necrosis. Am. J. Pathol. 169, 750 760. (Pubitemid 44411943)
33. Rodrigues B. McNeill J.H. (1992) The diabetic heart: causes for the development of a cardiomyopathy. Cardiovasc. Res. 26, 913 922.
34. Saraste A., Pulkki K., Kallajoki M. et al. (1999) Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur. J. Clin. Invest. 29, 380 386. (Pubitemid 29209759)
35. Schaper J., Froede R., Hein S. (1991) Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 83, 504 514.
36. Schulz R. Ali M.A.M. (2007) PPARα: essential component to prevent myocardial oxidative stress? Am. J. Physiol. Heart. Circ. Physiol. 293, H11 H12.
37. Shimizu M., Umeda K., Sugihara N. et al. (1993) Collagen remodelling in myocardia of patients with diabetes. J. Clin. Pathol. 46, 32 36. (Pubitemid 23039583)
38. Tagawa H., Wang N., Narishige T., Ingber D.E., Zile M.R., Cooper G. IV. (1997) Cytoskeletal mechanics in pressure-overloaded cardiac hypertrophy. Circ. Res. 80, 281 289. (Pubitemid 27058701)
39. Tagawa H., Koid M., Sato H., Zile M.R., Carabello B.A., Cooper G. IV. (1998) Cytoskeletal role in the transition from compensated to decompensated hypertrophy during adult canine left ventricular pressure overloading. Circ. Res. 82, 751 761. (Pubitemid 28185842)
40. Takashima K., Ito Y., Gonzalez F., Nakajima T. (2008) Different mechanisms of DEHP-induced hepatocellular adenoma tumorigenesis in wild-type and Pparα-null mice. J. Occup. Health 50, 169 180.
41. Tontonoz P., Hu E., Spiegelmann B.M. (1994) Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid -activated transcription factor. Cell 79, 1147 1156.
42. Vamecq J. Latruffe N. (1999) Medical significance of peroxisome proliferator-activated receptors. Lancet 354, 141 148. (Pubitemid 29313157)
43. Wang X., Li F., Campbell S.E., Gerdes A.M. (1999) Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: II. Cytoskeletal remodelling. Mol. Cell. Cardiol. 31, 319 331. (Pubitemid 29089881)
44. Wencker D., Chandra M., Nguyen K. et al. (2003) A mechanistic role for cardiac myocyte apoptosis in heart failure. J. Clin. Invest. 111, 1497 1504. (Pubitemid 38063282)
45. Zanetti M., Stocca A., Dapas B. et al. (2008) Inhibitory effects of fenofibrate on apoptosis and cell proliferation in human endothelial cells in high glucose. J. Mol. Med. 86, 185 195.
46. Zile M.R., Green G.R., Schuyler G.T., Aurigemma G.P., Miller D.C., Cooper G. IV. (2001) Cardiocyte cytoskeleton in patients with left ventricular pressure overload hypertrophy. J. Am. Coll. Cardiol. 37, 1080 1084. (Pubitemid 32217610)
47. Zollinger U. (1983) Chromotrop-aniline blue stain for improved demonstration of fresh heart muscle fiber damage. Z. Rechtsmed. 90, 269 275.